{
  "id": "enwiki-001359574986",
  "slug": "5ia",
  "title": "Α5IA",
  "qid": "",
  "lead": "α 5 IA (LS-193,268) is a nootropic drug invented in 2004 by a team working for Merck, Sharp and Dohme, which acts as a subtype-selective inverse agonist at the benzodiazepine binding site on the GABA A receptor. It binds to α 1 , α 2 , α 3 and α 5 -containing subtypes, with functional selectivity for α 5 -containing subtypes.",
  "body": "α 5 IA (LS-193,268) is a nootropic drug invented in 2004 by a team working for Merck, Sharp and Dohme, which acts as a subtype-selective inverse agonist at the benzodiazepine binding site on the GABA A receptor. It binds to α 1 , α 2 , α 3 and α 5 -containing subtypes, with functional selectivity for α 5 -containing subtypes.",
  "categories": [],
  "license": "CC BY-SA 4.0",
  "source_uri": "https://en.wikipedia.org/w/index.php?oldid=1359574986",
  "content_hash": "",
  "created_at": null,
  "updated_at": 1781566205.0,
  "claims": [],
  "contradictions": [],
  "confidence": 0.6,
  "csl": {
    "id": "enwiki-001359574986",
    "type": "webpage",
    "title": "Α5IA",
    "author": [
      {
        "family": "Anticloud FZ LLE",
        "literal": "Anticloud FZ LLE"
      }
    ],
    "container-title": "encyclopegia.org",
    "publisher": "Anticloud FZ LLE",
    "publisher-place": "Dubai, United Arab Emirates",
    "URL": "https://encyclopegia.org/a/5ia",
    "issued": {
      "date-parts": [
        [
          2026,
          11,
          21
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          2026,
          11,
          21
        ]
      ]
    },
    "license": "CC BY-SA 4.0",
    "DOI": "eo1:enwiki-001359574986",
    "isBasedOn": "https://en.wikipedia.org/w/index.php?oldid=1359574986",
    "note": "Immutable snapshot enwiki-001359574986"
  }
}